ABTA Awards $50k Grant for Study of Energy Pathway in Glioblastoma


Atsuo Sasaki, PhD, at the Vontz Center for Molecular Studies. Photo by Cindy Starr.

The highly malignant brain cancer known as glioblastoma multiforme is an energy guzzler. To sustain the tumor’s rapid cell division and proliferation, glioblastoma cells harness a specific molecule that enables them to ramp up energy production.

What if that energy spigot could be turned off and glioblastoma cells ran out of fuel? It is an idea so intriguing that the American Brain Tumor Association (ABTA) has awarded a $50,000 grant to Atsuo Sasaki, PhD, to find out.

Dr. Sasaki, Assistant Professor in the Division of Hematology-Oncology at the University of Cincinnati College of Medicine, will work with members of his lab at the UC Brain Tumor Center to test whether they can interfere with the disregulated energy molecule, guanosine triphosphate (GTP), and suppress the GTP pathway.

“This award means a lot to me, because a national foundation has recognized our work,” Dr. Sasaki says.

“The ABTA research award is a tribute to Dr. Sasaki, his laboratory team and the vision of the UC Brain Tumor Center,” says Ronald Warnick, MD, Medical Director of the Center and the John M. Tew, Jr., MD, Chair in Neurosurgical Oncology at UC. “We are determined to bring hope to our patients through translational research that moves science forward and leads us in the direction of new, life-saving therapies.”

The Brain Tumor Center is part of the UC Neuroscience Institute and the UC Cancer Institute, which are part of the UC College of Medicine and UC Health.

The ABTA grant presents Dr. Sasaki with an opportunity to explore his theory of energy utilization in cancer cells, which he developed after coming to the UC Brain Tumor Center in 2012.

Dr. Sasaki  likens brain tumors to large, gas-guzzling vehicles that use lots of fuel to get where they need to go. “And, like gas-guzzling vehicles,” he says, “brain cancer cells require frequent trips to the gas station to fill up their tank.”

This need to continually refuel is a vulnerability that offers a potential opportunity to scientists, he says. “If we can keep the tumor cells from acquiring more fuel, they will expire. We know that if this system is disrupted – if the cells run out of gas – they are going to die.”

Pharmacological inhibition of the GTP pathway, Dr. Sasaki adds, is unlikely to affect normal brain cells. Unlike glioblastoma cells, normal brain cells utilize a distinctive, fuel-efficient energy metabolism and should be able to maintain their energy levels.

Dr. Sasaki’s immediate objective is to understand how suppression of the brain tumor-specific energy pathway impacts glioblastoma cells, cultured in a petri dish, and in a rodent model of glioblastoma. Dr. Sasaki theorizes that a “bottleneck target” in the energy pathway plays a role in the generation of GTP in glioblastoma cells.

The results of his investigation could prove significant. They could clarify the molecular link between glioblastoma and high GTP energy production. “Our research could result in a new and powerful strategy for the treatment of glioblastoma,” Dr. Sasaki says.

The approach also could become a therapy for metastatic brain tumors, which, like glioblastoma, are aggressive, energy-guzzling tumors.

The ultimate goal of Dr. Sasaki’s laboratory research is to acquire new knowledge that the UC Brain Tumor Center’s clinical team can translate into Phase I and II clinical trials for patients.

— Cindy Starr

This entry was posted in Press Releases, UCNI Weekly Blog. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • Sign up for our newsletter!
  • Hope Stories

    • Troy’s Story: Proton Therapy for Brain Cancer

      Troy's Story: Proton Therapy for Brain Cancer Troy Witt, 65, a London, Kentucky resident and a self-proclaimed "country boy,” says he loves his family, fishing, woodworking and riding on his tractor. But all of these activities have been put on hold since spring 2016 when Witt’s...
    • Jim’s Story: Acromegaly / Pituitary Tumor

      Jim's Story: Acromegaly / Pituitary Tumor Four years later, Jim’s story just keeps getting better. Because four years after being treated for a pituitary tumor at the UC Brain Tumor Center, Jim continues to feel better and better. The size of his head has gone down....
    • Lynne’s Story: Brain Metastasis

      Lynne's Story: Brain MetastasisSemiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Bob’s Story: Recurrent Glioblastoma

      Bob's Story: Recurrent Glioblastoma Glioblastomas come back. Sometimes sooner, sometimes later, but they always come back. “That’s the...
    • Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’

      Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’ Troy Sheldon has something to say, and he’d like...
    • Brian’s Story: Meningioma

      Brian's Story: Meningioma “Carefree” is the word Brian uses to describe his life back then. He was 39 years old, happily married and the father of three children under the age of 5. “Life was busy, but that felt normal,” he says, reflecting. “The only...
    • Jerry’s Story: Spinal Tumor

      Jerry's Story: Spinal Tumor On an ordinary day in February 2009, John M. Tew, MD, got one of the true surprises of his career. He was seeing patients in his Mayfield Clinic office on the University of Cincinnati medical campus when an unexpected guest...